The deregulation of VAV2 expression or activity has been associated with cancer, autoimmune and neurological disorders (Huang et al., 2019; Patel et al., 2007; Pickering et al., 2021; Rodriguez-Fdez et al., 2021; Ruggiero and Lalli, 2017). The gene discussed is VAV2; the disease is cancer.